BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21402675)

  • 1. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC; Zhang JJ; Chen M; Lv JC; Liu G; Zou WZ; Zhang H; Zhao MH
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria.
    Xu PC; Wei L; Shang WY; Tian SL; Gu DM; Yan TK; Lin S
    BMC Nephrol; 2014 Jul; 15():107. PubMed ID: 24998891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIM-1 expression predicts renal outcomes in IgA nephropathy.
    Kwon SH; Park MY; Jeon JS; Noh H; Choi SJ; Kim JK; Hwang SD; Jin SY; Han DC
    Clin Exp Nephrol; 2013 Jun; 17(3):359-64. PubMed ID: 23135864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy.
    Seo MS; Park MY; Choi SJ; Jeon JS; Noh H; Kim JK; Han DC; Hwang SD; Jin SY; Kwon SH
    BMC Nephrol; 2013 Jul; 14():139. PubMed ID: 23837450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
    Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
    Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
    Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.
    Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch-Schönlein Purpura Nephritis.
    Zhang Y; Li A; Wen J; Zhen J; Hao Q; Zhang Y; Hu Z; Xiao X
    Arch Med Res; 2017 Jul; 48(5):449-458. PubMed ID: 29122357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
    Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
    Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients.
    Malyszko J; Koc-Zorawska E; Malyszko JS; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):3957-9. PubMed ID: 21168598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
    Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
    Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.
    van Timmeren MM; Vaidya VS; van Ree RM; Oterdoom LH; de Vries AP; Gans RO; van Goor H; Stegeman CA; Bonventre JV; Bakker SJ
    Transplantation; 2007 Dec; 84(12):1625-30. PubMed ID: 18165774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG; Ye XH; Liang HY; Yang Q
    Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
    Chen J; Hu W; Xiao F; Lin L; Chen K; Wang L; Wang X; He Y
    Kidney Blood Press Res; 2019; 44(5):1063-1074. PubMed ID: 31487717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.